Скачать или смотреть RNAi Briefing: From Nobel Winning Science to Next Generation Treatment

RNA interference (RNAi) is a scientific breakthrough that, thanks to the determination of both academic and industry researchers, is empowering desperately needed progress against rare diseases. Global health threats like COVID-19 have further demonstrated the significance of this innovative platform.

The Research!America briefing, From Nobel Winning Science to Next Generation Treatment: Tracing the Path of a Rare Disease Breakthrough using RNAi, included discussion focusing on the influence of RNAi technology on medical progress. Participants explored the impact of RNAi technology in addressing unmet medical needs and demonstrated the symbiotic roles of the public and private sectors.

Moderator:
Elias A. Zerhouni, MD, professor emeritus, Johns Hopkins University, former director, National Institutes of Health, 2002-2008

Panelists:
Isabelle Lousada, president & CEO, Amyloidosis Research Consortium
Phillip A. Sharp, PhD, institute professor, and professor of Biology, MIT; member, Koch Institute for Integrative Cancer Research at MIT; 1993 Nobel Prize in Physiology or Medicine
Akshay Vaishnaw, MD, PhD, president, Research & Development, Alnylam Pharmaceuticals
Brian Zambrowicz, PhD, senior vice president, Functional Genomics and Chief VelociGene® Operations, Regeneron Pharmaceuticals